Valuation: Becton, Dickinson and Company

Market Cap 53.16B 47.65B 44.01B 39.89B 74.36B 5,061B 75.38B 527B 210B 2,649B 199B 195B 8,388B P/E 2026 *
38.7x
P/E 2027 * 23.1x
Enterprise Value 69.04B 61.89B 57.16B 51.81B 96.58B 6,574B 97.91B 684B 272B 3,440B 259B 254B 10,894B EV / Sales 2026 *
3.58x
EV / Sales 2027 * 3.4x
Free-Float
73.18%
Yield 2026 *
2.14%
Yield 2027 * 2.18%
1 day+0.07%
1 week+0.70%
Current month+9.03%
1 month+6.17%
3 months+22.80%
6 months+29.92%
Current year+0.56%
1 week 193.8
Extreme 193.8
200.47
1 month 175.71
Extreme 175.71
200.47
Current year 140.11
Extreme 140.11
213.08
1 year 140.11
Extreme 140.11
213.08
3 years 140.11
Extreme 140.11
259.92
5 years 140.11
Extreme 140.11
287.32
10 years 140.11
Extreme 140.11
287.32
Manager TitleAgeSince
Chief Executive Officer 53 2020-01-27
Director of Finance/CFO 44 2025-12-04
Chief Tech/Sci/R&D Officer 56 2023-12-03
Director TitleAgeSince
Director/Board Member 75 2002-09-23
Director/Board Member 71 2010-07-25
Chairman 53 2021-04-27
Date Insider Type Main position Quantity % Market Cap. Importance
9/28/26 Sell

Executive/Senior Manager

-76 0.0000%
9/2/26 Tax

Chief Financial Officer

-190 0.0001%
8/26/26 Sell

Executive/Senior Manager

-165 0.0001%
Change 5-day change 1-year change 3-year change Capi.($)
+0.07%+0.70%+4.34%-22.43% 53.12B
-0.45%+0.19%-19.30%+10.54% 178B
+0.86%-0.13%-20.78%+16.07% 116B
+0.88%+0.16%+0.69%+36.51% 115B
-2.26%+18.07%-43.85%+5.76% 93.1B
-0.31%-5.51%-3.48%+72.86% 62.09B
+0.17%+1.64%+8.50%+82.24% 55.87B
+0.30%+0.89%-13.05%+43.83% 44.22B
+0.10%+3.37%-4.73%-8.71% 33.59B
+0.08%-8.30%+11.31%-11.95% 29.65B
Average -0.06%+1.21%-8.03%+22.47% 78.07B
Weighted average by Cap. -0.10%+1.96%-12.50%+22.66%

Financials

2026 *2027 *
Net sales 19.29B 17.29B 15.97B 14.48B 26.98B 1,837B 27.35B 191B 76.13B 961B 72.37B 70.85B 3,044B 19.73B 17.68B 16.33B 14.8B 27.6B 1,878B 27.98B 195B 77.85B 983B 74.01B 72.46B 3,113B
Net income 1.41B 1.26B 1.16B 1.06B 1.97B 134B 1.99B 13.93B 5.55B 70.08B 5.28B 5.17B 222B 2.19B 1.96B 1.81B 1.64B 3.07B 209B 3.11B 21.71B 8.65B 109B 8.22B 8.05B 346B
Net Debt 15.88B 14.24B 13.15B 11.92B 22.22B 1,512B 22.53B 157B 62.69B 792B 59.59B 58.34B 2,506B 13.95B 12.51B 11.55B 10.47B 19.52B 1,328B 19.78B 138B 55.06B 695B 52.34B 51.24B 2,201B
Projected Income Statement - Annual - Becton, Dickinson and Company
Logo Becton, Dickinson and Company
Becton, Dickinson and Company specializes in the development, manufacturing and marketing of medical and diagnostic equipment and materials. Net sales break down by family of products as follows: - medical management systems (52.4%): medication delivery systems, pharmaceutical systems, advanced patient monitoring systems, etc.; - interventional medical equipment (23.9%): surgical instruments, urological care products, etc.; - diagnostic materials and clinical research and development tools (23.7%): automated systems for blood testing, mycobacteria detection, and molecular biology, medical biology devices, tools for studying genes and culturing cells, instruments for sorting and analyzing cells, monoclonal antibodies, etc. Net sales are distributed geographically as follows: the United States (58.6%), Europe/Middle East/Africa (21.6%), Asia (14.2%) and other (5.6%).
Employees
72,000
Date Price Change Volume
26-10-28 $195.16 +0.07% 1,739,275
26-10-27 $195.03 -0.69% 1,153,146
26-10-26 $196.39 -1.27% 1,640,118
26-10-23 $198.91 -0.75% 1,304,245
26-10-22 $200.42 +3.13% 1,383,256
Trader
Investor
Global
Quality
ESG MSCI
A
MarketScreener Ratings - Becton, Dickinson and Company
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
16
Last Close Price
195.16USD
Average target price
195.57USD
Spread / Average Target
+0.21%

Quarterly revenue - Rate of surprise

Rate of surprise - Net sales - Quarterly - Becton, Dickinson and Company